HOME >> BIOLOGY >> NEWS
Leading cloning experts challenge Clonaid to prove claim

PITTSBURGH, Jan. 6 In reaction to the recent claim by Clonaid that it had produced the first human clone, three international cloning experts emphasized that current cloning techniques have been shown to seriously compromise the health of cloned offspring. Randall Prather, distinguished professor of reproductive biotechnology at the University of Missouri-Columbia; Ian Wilmut, an embryologist at the Roslin Institute near Edinburgh, Scotland; and Gerald Schatten, professor and vice-chair of obstetrics, gynecology & reproductive sciences and cell biology-physiology at the University of Pittsburgh School of Medicine; said that it was highly likely that cloned children would suffer similar problems with their health and this alone should deter scientists from cloning human beings.

"All of the reports from cloning experiments describe a high incidence of late abortion or the birth of dead animals," Prather said. "When live cloned offspring have been produced, many have been subject to abnormalities that were apparent only after birth. These abnormalities include premature death at many different ages, respiratory failure, absence of an immune response and inadequate kidney function. These problems are believed to be a consequence of inappropriate gene expression resulting from incomplete 'reprogramming' of the adult cell used in cloning. There is absolutely no reason to expect the situation to be different in humans. Furthermore, human brain development is far more complex than in animals and the neuropsychiatric consequences for cloned children might be devastating. Until there is compelling and scientifically validated evidence that the situation is different in human embryos it is grossly irresponsible to attempt to clone children."

Wilmut, Schatten and Prather also strongly support independent tests by a respected authority, such as the National Academy of Sciences, to confirm that the DNA of Eve, the baby Clonaid claims is the first human clone, i
'"/>

Contact: Michele Baum
412-647-3555
University of Pittsburgh Medical Center
6-Jan-2003


Page: 1 2

Related biology news :

1. Leading scientists design new framework for biodiversity conservation
2. Leading science, higher-education and engineering groups urge six improvements to U.S. visa quagmire
3. Leading experts in field of gene therapy to meet in Minneapolis
4. Leading U.S. gun manufacturer joins NJIT to develop personalized handgun
5. Leading bacterial pathogen is sequenced
6. Leading cancer research organization urges FDA to speed approval of drugs for precancers
7. Leading lab expert to update medical community on diagnostic testing for thyroid function
8. Leading indoor environment experts to convene at Syracuse University to discuss air quality and urban environments
9. Leading snake expert dies at 38
10. Leading experts address safety and economics of biotech crops
11. Taking the show on the road - Leading researchers to conduct hands-on science symposium for 500 San Francisco area high school students

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Leading cloning experts challenge Clonaid prove claim

(Date:11/3/2014)... Research and Markets has announced the addition of a ... to their offering. This report describes ... started to play an important role in the practice of ... bone marrow transplants. Role of cells in drug discovery is ... of medical practice. Stem cells are discussed in ...
(Date:11/3/2014)... , Nov. 3, 2014  NeuroSigma ® ... -based life sciences company focused on commercialization of ... for the treatment of neurological and neuropsychiatric ... Industrial Property has issued a Notice of Allowance ... application is co-owned by NeuroSigma and the Regents ...
(Date:11/2/2014)... , James Dacey explores the ways in which physicists ... innovations from the lab into the commercial market. , ... companies as they move from prototype to product is ... physics-based inventions are usually far from market-ready when initially ... lot more complicated than had been originally thought. , ...
Breaking Biology News(10 mins):Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3The 'valley of death' facing physics start-ups 2
(Date:11/21/2014)... York, NY (PRWEB) November 20, 2014 ... is now available as an open access journal featuring ... with infrared fluorescent proteins to preserve photoresponsiveness in the ... Two-color fluorescent in situ hybridization using chromogenic substrates ... chips for DNA, RNA, and protein electrophoresis , ...
(Date:11/21/2014)... 21, 2014 2014 Deep Research ... is a professional and in-depth research report on ... information, like its definition, classification, application, and ... This report covers the international market analysis, including ... as the US, Europe, Asia, China, Japan etc. ...
(Date:11/21/2014)... Nov. 20, 2014 /CNW/ - Aequus Pharmaceuticals Inc. ... that it has closed a brokered private placement ... approximately C$3.7 million.  Cormark Securities Inc. and Clarus ... Brokered Offering for a syndicate of agents that ... Corp. (collectively the "Agents"). Concurrently with the Brokered ...
(Date:11/18/2014)... Nov. 18, 2014 Cord Blood Registry® (CBR®) ... the 10th Annual World Stem Cell Summit, the largest global ... 2014 World Stem Cell Summit will be held December 3-5 ... . The World Stem Cell ... lifesaving cures and therapies, convening the most prominent figures in ...
Breaking Biology Technology:BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 2BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 3Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 2Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 3Aequus Pharmaceuticals closes $4.2 million private placement financing 2Aequus Pharmaceuticals closes $4.2 million private placement financing 3Cord Blood Registry Sponsors 2014 World Stem Cell Summit 2Cord Blood Registry Sponsors 2014 World Stem Cell Summit 3
Cached News: